312 related articles for article (PubMed ID: 11731422)
1. Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy.
Minotti G; Ronchi R; Salvatorelli E; Menna P; Cairo G
Cancer Res; 2001 Dec; 61(23):8422-8. PubMed ID: 11731422
[TBL] [Abstract][Full Text] [Related]
2. The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein-1 in cytosolic fractions from human myocardium.
Minotti G; Recalcati S; Mordente A; Liberi G; Calafiore AM; Mancuso C; Preziosi P; Cairo G
FASEB J; 1998 May; 12(7):541-52. PubMed ID: 9576481
[TBL] [Abstract][Full Text] [Related]
3. Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity.
Minotti G; Cavaliere AF; Mordente A; Rossi M; Schiavello R; Zamparelli R; Possati G
J Clin Invest; 1995 Apr; 95(4):1595-605. PubMed ID: 7706466
[TBL] [Abstract][Full Text] [Related]
4. 4'-Epidoxorubicin to re-explore anthracycline degradation in cardiomyocytes.
Menna P; Salvatorelli E; Minotti G
Chem Res Toxicol; 2009 Jun; 22(6):978-83. PubMed ID: 19397277
[TBL] [Abstract][Full Text] [Related]
5. Lack of coordinate control of ferritin and transferrin receptor expression during rat liver regeneration.
Cairo G; Tacchini L; Pietrangelo A
Hepatology; 1998 Jul; 28(1):173-8. PubMed ID: 9657110
[TBL] [Abstract][Full Text] [Related]
6. Modulation of iron regulatory protein-1 by various metals.
Oshiro S; Nozawa K; Hori M; Zhang C; Hashimoto Y; Kitajima S; Kawamura K
Biochem Biophys Res Commun; 2002 Jan; 290(1):213-8. PubMed ID: 11779155
[TBL] [Abstract][Full Text] [Related]
7. Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.
Forrest GL; Gonzalez B; Tseng W; Li X; Mann J
Cancer Res; 2000 Sep; 60(18):5158-64. PubMed ID: 11016643
[TBL] [Abstract][Full Text] [Related]
8. Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: the role of reactive oxygen and nitrogen intermediates.
Konorev EA; Kennedy MC; Kalyanaraman B
Arch Biochem Biophys; 1999 Aug; 368(2):421-8. PubMed ID: 10441396
[TBL] [Abstract][Full Text] [Related]
9. Anthracycline metabolism and toxicity in human myocardium: comparisons between doxorubicin, epirubicin, and a novel disaccharide analogue with a reduced level of formation and [4Fe-4S] reactivity of its secondary alcohol metabolite.
Minotti G; Licata S; Saponiero A; Menna P; Calafiore AM; Di Giammarco G; Liberi G; Animati F; Cipollone A; Manzini S; Maggi CA
Chem Res Toxicol; 2000 Dec; 13(12):1336-41. PubMed ID: 11123976
[TBL] [Abstract][Full Text] [Related]
10. Unexpected anthracycline-mediated alterations in iron-regulatory protein-RNA-binding activity: the iron and copper complexes of anthracyclines decrease RNA-binding activity.
Kwok JC; Richardson DR
Mol Pharmacol; 2002 Oct; 62(4):888-900. PubMed ID: 12237336
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanisms.
Minotti G; Recalcati S; Menna P; Salvatorelli E; Corna G; Cairo G
Methods Enzymol; 2004; 378():340-61. PubMed ID: 15038979
[No Abstract] [Full Text] [Related]
12. Nitric oxide and peroxynitrite-dependent aconitase inactivation and iron-regulatory protein-1 activation in mammalian fibroblasts.
Castro LA; Robalinho RL; Cayota A; Meneghini R; Radi R
Arch Biochem Biophys; 1998 Nov; 359(2):215-24. PubMed ID: 9808763
[TBL] [Abstract][Full Text] [Related]
13. Chronic cardiotoxicity of anticancer anthracyclines in the rat: role of secondary metabolites and reduced toxicity by a novel anthracycline with impaired metabolite formation and reactivity.
Sacco G; Giampietro R; Salvatorelli E; Menna P; Bertani N; Graiani G; Animati F; Goso C; Maggi CA; Manzini S; Minotti G
Br J Pharmacol; 2003 Jun; 139(3):641-51. PubMed ID: 12788824
[TBL] [Abstract][Full Text] [Related]
14. Identification of RNA-binding surfaces in iron regulatory protein-1.
Kaldy P; Menotti E; Moret R; Kühn LC
EMBO J; 1999 Nov; 18(21):6073-83. PubMed ID: 10545118
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin metabolism and toxicity in human myocardium: role of cytoplasmic deglycosidation and carbonyl reduction.
Licata S; Saponiero A; Mordente A; Minotti G
Chem Res Toxicol; 2000 May; 13(5):414-20. PubMed ID: 10813659
[TBL] [Abstract][Full Text] [Related]
16. Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking.
Xu X; Sutak R; Richardson DR
Mol Pharmacol; 2008 Mar; 73(3):833-44. PubMed ID: 18029550
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains.
Piñero DJ; Hu J; Connor JR
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):761-76. PubMed ID: 10875438
[TBL] [Abstract][Full Text] [Related]
18. Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism.
Cusack BJ; Gambliel H; Musser B; Hadjokas N; Shadle SE; Charlier H; Olson RD
Cancer Chemother Pharmacol; 2006 Oct; 58(4):517-26. PubMed ID: 16555089
[TBL] [Abstract][Full Text] [Related]
19. Iron regulatory proteins 1 and 2.
Henderson BR
Bioessays; 1996 Sep; 18(9):739-46. PubMed ID: 8831290
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide and peroxynitrite activate the iron regulatory protein-1 of J774A.1 macrophages by direct disassembly of the Fe-S cluster of cytoplasmic aconitase.
Cairo G; Ronchi R; Recalcati S; Campanella A; Minotti G
Biochemistry; 2002 Jun; 41(23):7435-42. PubMed ID: 12044177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
